{"id":43354,"date":"2020-12-15T08:27:33","date_gmt":"2020-12-15T16:27:33","guid":{"rendered":"https:\/\/www.salesforce.com\/?post_type=sf_press_release&p=43354"},"modified":"2021-01-27T14:11:02","modified_gmt":"2021-01-27T22:11:02","slug":"gavi-salesforce-vaccine-alliance","status":"publish","type":"sf_press_release","link":"https:\/\/www.salesforce.com\/news\/press-releases\/2020\/12\/15\/gavi-salesforce-vaccine-alliance\/","title":{"rendered":"Gavi, the Vaccine Alliance, Collaborates with Salesforce to Help Equitably Distribute Two Billion COVID-19 Vaccines by the End of 2021"},"content":{"rendered":"\n

COVAX is the global initiative that will make COVID-19 vaccines available for 190 countries, including the poorest in the world<\/em><\/p>\n\n\n\n

SAN FRANCISCO \u2014 December 15, 2020 <\/strong>\u2014 Salesforce, the global leader in CRM (NYSE: CRM), and Gavi, the Vaccine Alliance, announced today that they will collaborate to help Gavi manage critical information to equitably distribute approximately two billion COVID-19 vaccines to 190 countries by the end of 2021. <\/p>\n\n\n\n

Fair, rapid and equitable access to vaccines is critical to ending the global pandemic. Public-private partnerships, such as Gavi, which are focused on getting vaccines to some of the world\u2019s poorest countries, need to be armed with data and technology to facilitate distribution at scale. The ability to manage huge volumes of country data is essential.<\/p>\n\n\n\n

In June, Gavi and other partners launched COVAX, a global alliance whose goal is to ensure that people in all corners of the world get access to COVID-19 vaccines, regardless of their wealth. COVAX will achieve this by supporting the research, development and manufacturing of a wide range of COVID-19 vaccine candidates, and also negotiating pricing and distribution for the 190 countries that have joined the alliance to date. <\/p>\n\n\n

\n
Open Image Modal<\/span>\"Vaccine<\/a><\/figure>\n
<\/div>